Interesting ImagesParathyroid Carcinoma Shown on 99mTc-Sestamibi Parathyroid SPECT/CT Scan in a Pediatric PatientWang, Wei MD, PhD; Liu, Jun MD; Liu, Jie MD, PhD; Yang, Jigang MD, PhDAuthor Information From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China. Received for publication January 14, 2020; revision accepted January 20, 2020. Conflicts of interest and sources of funding: J.Y. was supported by the National Natural Science Foundation of China (nos. 81771860, 81971642), Beijing Natural Science Foundation (no. 7192041), and the National Key Research and Development Plan (no. 2017YFC0114003). Correspondence to: Jigang Yang, MD, PhD, Nuclear Medicine Department, BeiJing Friendship Hospital affiliated to Capital Medial University, 95 YongAn Road, XiCheng District, BeiJing, China, 100050. E-mail: firstname.lastname@example.org. Online date: March 24, 2020 Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p 480-482 doi: 10.1097/RLU.0000000000002998 Buy Metrics Abstract A 10-year-old boy presented with back pain. 99mTc-methylene diphosphonate bone scan demonstrated the sign of metabolic bone disease, suspected due to hyperparathyroidism. 99mTc-sestamibi parathyroid SPECT/CT demonstrated focal lesion in the lower pole of the right lobe. The pathological examination demonstrated parathyroid carcinoma, which is very rare in pediatric population. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.